CELG : Summary for Celgene Corporation - Yahoo Finance

U.S. Markets closed

Celgene Corporation (CELG)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
121.78+3.55 (+3.00%)
At close: 4:00PM EST

121.85 0.07 (0.06%)
After hours: 7:15PM EST

People also watch
GILDBIIBREGNAMGNALXN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close118.23
Open118.30
Bid121.66 x 100
Ask121.89 x 100
Day's Range118.01 - 122.00
52 Week Range94.39 - 127.00
Volume3,619,838
Avg. Volume4,264,383
Market Cap94.74B
Beta1.52
PE Ratio (TTM)48.91
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Achillion (ACHN) Reports Narrower-Than-Expected Q4 Loss
    Zacks12 hours ago

    Achillion (ACHN) Reports Narrower-Than-Expected Q4 Loss

    Shares of Achillion Pharmaceuticals, Inc. (ACHN) lost almost 9% on Feb 24, 2017, in spite of the company reporting narrower-than-expected fourth-quarter loss a day before.

  • Business Wire13 hours ago

    Celgene Corporation to Webcast at Upcoming Investor Conferences

    Celgene Corporation plans to present at two upcoming investor conferences where Celgene management will provide an overview of the Company. The conferences will be webcast live and will be available in the Investor Relations section of the Company’s website at www.celgene.com.

  • Emergent (EBS) Beats Earnings, Revenue Estimates in Q4
    Zacks3 days ago

    Emergent (EBS) Beats Earnings, Revenue Estimates in Q4

    Emergent BioSolutions, Inc. (EBS) reported earnings of 74 cents per share in the fourth quarter of 2016, which surpassed the Zacks Consensus Estimate of 60 cents. However, the reported figure decreased from 77 cents earned in the year-ago period.